The Road to Renewables

Thomas Thune Andersen, former Chair of Ørsted, reflects on a decade of transformative leadership. He talks to Criticaleye’s Emily Jones about steering the Danish company’s business model from fossil fuels to becoming the world’s largest offshore wind farm developer.

Criticaleye provides Chairs, NEDs and SIDs with bespoke support designed to nurture high performance at Board level. With 56 percent of respondents in our Chair & NED Research saying they strongly believe Boards require external reference points, Criticaleye facilitates a unique environment to benchmark with Board-level peers from various organisations, sectors and regions.
 
Click here to find out more about how we support Board leaders.




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
Investing in the Green Econom...

Transitioning to a more sustainable economic system that balances economic development with maintaining healthy global ecosystems requires significant investment. In this fifth edition of their annual Green Economy R...

Click here to download this insight
The Journey to Group CFO

A common route to the Group CFO position involves stepping up from a divisional role. Tobias Hestler did exactly that leading up to 2022 but with the added complexity of taking up the Group position in a newly formed bu...

Click here to download this insight
The Empowered Consumer

In a world where companies are increasingly focusing on customer-centricity and personalised experiences, why are 74 percent of consumers walking away from purchases? In this report, Criticaleye Partner Accenture&n...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 537




Drax Group plc Concentrix Salesforce Eton Bridge Partners Royal London Group Bunzl plc London Stock Exchange AlixPartners Mayborn Group Tullow Oil plc Google LDC Legal & General Investment Management Eightfold AI Workday Amazon UK E.ON UK NATS Robert Walters Lightsource bp Experian Veolia Water Technologies Redwood Bank Accenture GlaxoSmithKline plc